Please use this identifier to cite or link to this item: http://repository.ush.edu.sd:8080/xmlui/handle/123456789/429
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYousif Elemam, Ibrahim Bakhit-
dc.date.accessioned2018-05-21T08:58:06Z-
dc.date.available2018-05-21T08:58:06Z-
dc.date.issued2015-09-01-
dc.identifier.citationLMP-1 IMMUNOHISTOCHEMICAL DETECTION OF EPSTEIN - BARR VIRUS IN LYMPHOMA AMONG SUDANESE PATIENTSen_US
dc.identifier.issnISSN- 2350-0530(O)-
dc.identifier.issn2394-3629(P)-
dc.identifier.urihttp://hdl.handle.net/123456789/429-
dc.descriptionCite This Article: Ibrahim Bakhit Yousif , Yousif Mohammed Yousif, and Mohammed Sideeg Abd Elaziz, “LMP-1 IMMUNOHISTOCHEMICAL DETECTION OF EPSTEIN - BARR VIRUS IN LYMPHOMA AMONG SUDANESE PATIENTS” International Journal of Research – Granthaalayah, Vol. 3, No. 9(2015): 63-69.en_US
dc.description.abstractSeveral studies have suggested a probable etiologic association between Epstein-Barr virus (EBV) and lymphoma; multiple EBV proteins can be expressed in infected lymphocytes, among which Latent membrane protein-1(LMP-1) is thought to be most important for malignant transformation, the aim of this study was to investigate the association of LMP-1 EBV in this tumors. This study was carried at the Radio Isotope Center Khartoum (RICK)- Khartoum state –Sudan from January 2015 to July 2015, it was retrospective and prospective, the study include ninety (90) Formalin –fixed paraffin embedded biopsies from which seventy (70) of malignant lymphoma (study group) and twenty (20) lymph node hyperplasia (control group ). EBV was detected in (32%) (23/70), and (10%) (2/20) respectively, the (P.value =0.04), this result showed a significant difference between case and control groups, the, there is no statistically significant difference between the two lymphoma subtypes Hodgkin's and Non-Hodgkin`s the (P.value= 0.333). There is sufficient evidence for the carcinogenicity of EBV in the causation of lymphoma in Sudan. This requires further evaluation to find out whether this positivity is due to co-infection or has a role in pathogenesis.en_US
dc.description.sponsorshipShendi Universityen_US
dc.language.isoenen_US
dc.publisherInternational Journal of Research Granthaalayahen_US
dc.relation.ispartofseriesYousif et. al., Vol.3;(Iss.9)-
dc.subjectEpstein-Barr virus, malignant lymphomas, lymph node hyperplasia, Hodgkin’s disease, Immunohistochemistry, Sudan.en_US
dc.subjectSudanen_US
dc.subjectEpstein-Barr virusen_US
dc.subjectmalignant lymphomasen_US
dc.subjectlymph node hyperplasiaen_US
dc.subjectHodgkin’s diseaseen_US
dc.subjectImmunohistochemistryen_US
dc.titleLMP-1 IMMUNOHISTOCHEMICAL DETECTION OF EPSTEIN - BARR VIRUS IN LYMPHOMA AMONG SUDANESE PATIENTSen_US
dc.title.alternativeLMP-1 IMMUNOHISTOCHEMICAL DETECTION OF EPSTEIN - BARR VIRUS IN LYMPHOMA AMONG SUDANESE PATIENTSen_US
dc.typeArticleen_US
Appears in Collections:Researches and Scientific Papers البحوث والأوراق العلمية

Files in This Item:
File Description SizeFormat 
LMP-1 IMMUNOHISTOCHEMICAL DETECTION OF EPSTEIN - BARR.pdf722.33 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.